Therefore, high PD-L1 expression on tumor cells—a good prognostic marker during anti-PD-1/PD-L1 therapy—does not invariably indicate a favorable antitumor response via PD-1/PD-L1 inhibition. The gene discussed is CD274; the disease is neoplasm.